Senna Leaf and Laxatives: Key Regulatory Differences Buyers Must Know

Senna Leaf and Laxatives: Key Regulatory Differences Buyers Must Know

Summary

Senna leaf and the senna extract used in laxatives share the same active ingredients, sennosides A and B. Their regulatory treatment varies by market: China allows them in pharmaceuticals and health foods with the Blue Hat mark, but bans them in ordinary foods. The industry standard T/CNHFA 111.104-2024 has taken effect.

The US FDA recognises them as OTC ingredients, while Australia requires TGA registration with an AUST L/R number.

Commentary

Senna extract originates from the same source as traditional Chinese medicine decoction pieces, but its regulatory status dictates market access. In China, it is restricted to pharmaceuticals and Blue Hat health foods, with ordinary foods prohibited. The US regulates it as an OTC or dietary supplement, while Australia requires TGA registration.

For Australian and New Zealand brands entering China, the cross-border ordinary food channel is not an option; they must complete health food registration and comply with the T/CNHFA 111.104-2024 raw material standard. TGA registration is not mutually recognised in China, so separate compliance efforts are needed. The new raw material standard is set to eliminate non-compliant extract suppliers, driving an industry upgrade.

New Zealand SMEs should prioritise suppliers with multi-country certifications to mitigate customs clearance and channel risks.

Keywords: Senna leaf, laxatives, regulation, health foods, OTC, TGA, ARTG, industry standard, compliance


Source: Sina

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.